152 related articles for article (PubMed ID: 12637253)
1. Curcumin attenuates DNB-induced murine colitis.
Salh B; Assi K; Templeman V; Parhar K; Owen D; Gómez-Muñoz A; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2003 Jul; 285(1):G235-43. PubMed ID: 12637253
[TBL] [Abstract][Full Text] [Related]
2. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis.
Camacho-Barquero L; Villegas I; Sánchez-Calvo JM; Talero E; Sánchez-Fidalgo S; Motilva V; Alarcón de la Lastra C
Int Immunopharmacol; 2007 Mar; 7(3):333-42. PubMed ID: 17276891
[TBL] [Abstract][Full Text] [Related]
3. Curcumin improves TNBS-induced colitis in rats by inhibiting IL-27 expression via the TLR4/NF-κB signaling pathway.
Zeng Z; Zhan L; Liao H; Chen L; Lv X
Planta Med; 2013 Jan; 79(2):102-9. PubMed ID: 23250811
[TBL] [Abstract][Full Text] [Related]
4. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice.
Sugimoto K; Hanai H; Tozawa K; Aoshi T; Uchijima M; Nagata T; Koide Y
Gastroenterology; 2002 Dec; 123(6):1912-22. PubMed ID: 12454848
[TBL] [Abstract][Full Text] [Related]
5. Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.
Epstein J; Docena G; MacDonald TT; Sanderson IR
Br J Nutr; 2010 Mar; 103(6):824-32. PubMed ID: 19878610
[TBL] [Abstract][Full Text] [Related]
6. A potential role for the vanilloid receptor TRPV1 in the therapeutic effect of curcumin in dinitrobenzene sulphonic acid-induced colitis in mice.
Martelli L; Ragazzi E; di Mario F; Martelli M; Castagliuolo I; Dal Maschio M; Palù G; Maschietto M; Scorzeto M; Vassanelli S; Brun P
Neurogastroenterol Motil; 2007 Aug; 19(8):668-74. PubMed ID: 17640182
[TBL] [Abstract][Full Text] [Related]
7. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
Zhang M; Deng C; Zheng J; Xia J; Sheng D
Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
[TBL] [Abstract][Full Text] [Related]
8. [Modulation of intestinal mucosal inflammatory factors by curcumin in rats with colitis].
Jian YT; Wang JD; Mai GF; Zhang YL; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec; 24(12):1353-8. PubMed ID: 15604057
[TBL] [Abstract][Full Text] [Related]
9. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis.
Ukil A; Maity S; Karmakar S; Datta N; Vedasiromoni JR; Das PK
Br J Pharmacol; 2003 May; 139(2):209-18. PubMed ID: 12770926
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells.
Liang KC; Lee CW; Lin WN; Lin CC; Wu CB; Luo SF; Yang CM
J Cell Physiol; 2007 Jun; 211(3):759-70. PubMed ID: 17311279
[TBL] [Abstract][Full Text] [Related]
11. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
12. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells.
Foryst-Ludwig A; Neumann M; Schneider-Brachert W; Naumann M
Biochem Biophys Res Commun; 2004 Apr; 316(4):1065-72. PubMed ID: 15044093
[TBL] [Abstract][Full Text] [Related]
13. Curcumin attenuates inflammatory responses of TNF-alpha-stimulated human endothelial cells.
Kim YS; Ahn Y; Hong MH; Joo SY; Kim KH; Sohn IS; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
J Cardiovasc Pharmacol; 2007 Jul; 50(1):41-9. PubMed ID: 17666914
[TBL] [Abstract][Full Text] [Related]
14. Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets.
Cho JW; Lee KS; Kim CW
Int J Mol Med; 2007 Mar; 19(3):469-74. PubMed ID: 17273796
[TBL] [Abstract][Full Text] [Related]
15. Curcumin reverses attenuated carbachol-induced contraction of the colon in a rat model of colitis.
Lubbad AS; Oriowo MA; Khan I
Scand J Gastroenterol; 2009; 44(2):187-94. PubMed ID: 18830899
[TBL] [Abstract][Full Text] [Related]
16. Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis.
Shakibaei M; John T; Schulze-Tanzil G; Lehmann I; Mobasheri A
Biochem Pharmacol; 2007 May; 73(9):1434-45. PubMed ID: 17291458
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice.
Leclercq IA; Farrell GC; Sempoux C; dela Peña A; Horsmans Y
J Hepatol; 2004 Dec; 41(6):926-34. PubMed ID: 15582125
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory activity of 4-methoxyhonokiol is a function of the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via NF-kappaB, JNK and p38 MAPK inactivation.
Zhou HY; Shin EM; Guo LY; Youn UJ; Bae K; Kang SS; Zou LB; Kim YS
Eur J Pharmacol; 2008 May; 586(1-3):340-9. PubMed ID: 18378223
[TBL] [Abstract][Full Text] [Related]
19. Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid-induced colitis: the roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.
Topcu-Tarladacalisir Y; Akpolat M; Uz YH; Kizilay G; Sapmaz-Metin M; Cerkezkayabekir A; Omurlu IK
J Med Food; 2013 Apr; 16(4):296-305. PubMed ID: 23566056
[TBL] [Abstract][Full Text] [Related]
20. Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid.
Jian YT; Mai GF; Wang JD; Zhang YL; Luo RC; Fang YX
World J Gastroenterol; 2005 Mar; 11(12):1747-52. PubMed ID: 15793857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
